A ring company buys a clinic
Oura announced on Tuesday that it will acquire Counsel Health, an AI-native primary care company, for $625 million in cash. It is the clearest signal yet that the company which made the smart ring a mainstream object intends to stop being a hardware company and start being a health platform.
Counsel is no stranger to Oura members. Its service — a chat-based medical experience backed by licensed physicians — was integrated into the Oura app in June. Members ask Counsel's medical AI for personalised advice and escalate to a human physician when a question needs one. Under the deal, the two companies say they will build out preventative care, acute care, and specialty and chronic care.
"Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals," Oura CEO Tom Hale said.
The numbers behind the timing
Oura's own results explain how it can afford this. Revenue grew 153% year over year to $533 million in the quarter ended September 30, and the company says it generated roughly $1.75 billion in fiscal 2026, up 92%. It reached an $11 billion valuation after a $900 million late-stage round in October 2025.
The timing is the interesting part. Weeks earlier, Oura postponed indefinitely what would have been an IPO of up to $2.2 billion, citing "uncertainty in the IPO market." Rather than sell equity to the public, it is spending cash on clinical capability.
What Oura is actually buying
Counsel Health raised a $25 million Series A a year ago led by Andreessen Horowitz and GV; PitchBook estimates it had raised about $36 million in total. CEO Muthu Alagappan joins Oura as chief clinical AI officer, and Counsel's 70 employees come with him, according to Bloomberg. The company will keep serving its existing and new enterprise partners, and Oura says it wants to extend the AI-native care model beyond its own membership.
What to watch
- **A long close.** The deal is expected to close before the end of 2027 — a lengthy runway for healthcare regulatory review. - **Ring competition.** RingConn and Ultrahuman are eating into Oura's lead, part of why the company wants revenue that is not a piece of titanium. - **The clinical-AI argument.** Oura's pitch is that continuous biometrics make AI advice safer, because a clinician sees trended data instead of a self-report.
The bet is that continuous physiology plus a licensed clinician is a bundle nobody else can assemble quickly. Whether regulators and payers agree is the next question.
Sources
- techcrunch.comTechCrunch — Oura to acquire AI-native primary care startup Counsel Health for $625M
- endpoints.newsEndpoints News — Oura to buy AI care startup Counsel Health for $625M
- gurufocus.comGuruFocus — Oura (OURA) Expands AI-Driven Healthcare with $625M Counsel Health Acquisition
- fourweekmba.comFourWeekMBA — Oura Pays $625M Cash for AI Care Firm Counsel

